Skip to search formSkip to main contentSkip to account menu

{4 (risedronate sodium 35 MG Oral Tablet) } Pack

Known as: RISEDRONATE NA 35MG TAB_#2, risedronate sodium 35 MG Oral Tablet, 4 Week Pack, RISEDRONATE SODIUM MONOHYDRATE 35 mg ORAL TABLET, FILM COATED_#2 
National Institutes of Health

Related topics

Related topics

28 relations
Aluminum OxideCroscarmelloseCrospovidoneFD&C yellow no. 6

Broader (1)

HORMONES/SYNTHETICS/MODIFIERS,OTHER

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
Background Intermittent dosing regimens for oral risedronate (once-monthly and once-weekly) were developed for patient… 
2019
2019
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
SummaryThe use of gastro-resistant risedronate, a convenient dosing regimen for oral bisphosphonate therapy, seems a cost… 
2015
2015
Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients.
INTRODUCTION Bisphosphonates may aid in treating and preventing bone loss promoted by chronic immunosuppressive treatment and… 
2015
2015
Effect of Combined Teriparatide and Monthly Risedronate Therapy on Cancellous Bone Mass in Orchidectomized Rats: A Bone Histomorphometry Study
This study investigated the effects of combined teriparatide (an anabolic agent) and monthly risedronate (an anti-resorptive… 
2014
2014
Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism
The objective of the study was to evaluate the effect of parathyroidectomy (PTX) versus 35 mg once-weekly (ow) risedronate… 
2014
2014
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate…
Aim: The aim of the following study is to evaluate adherence and compliance of postmenopausal osteoporotic patients for different… 
2012
2012
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
SummaryThis study showed that risedronate 150-mg once a month provides similar efficacy and safety at 2 years compared with… 
Highly Cited
2006
Highly Cited
2006
Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate*
ABSTRACT Objectives: To determine how patients' preferences for weekly versus monthly bisphosphonate therapy is influenced by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)